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PREAMBLE 
A researcher is like a person in the library of Babel skimming the book of sand 
for the script of the godhead. In this search for knowledge a study of the immune 
system offers a challenging opportunity, since this group of cells reflects a behaviour 
which has many similarities with that of the people studying it. Although the repertoire 
of immunologists is much smaller than that of the lymphocytes in each one of them, 
the diversity of its publications yet puts the writer of a thesis on the behaviour of the 
immune system in the situation described in the first line. Lending an axiom from Glenn 
Gould, my introducer to Jorge Luis Borges - the writer of the stories mentioned in line 
one -, the only reason to write a thesis is to do it differently. With this in mind I have 
not chosen to write an encyclopedia with my own contributions in the center of the 
immunological universe, but to combine some of the publications I wrote during the 
last four years, to provide some theoretical background on the problems they address 
and to focus on the ideas they reflect. 
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CHAPTER 1 
GENERAL INTRODUCTION 
An adult mouse has a population of about 109 lymphocytes. These cells have 
clonally distributed cell surface receptors, which are generated by somatic rearrange-
ments of DNA segments. The large number of these segments and the permutational 
nature of the recombinatory processes result in. an immense collection of different 
receptors, the so-called "specificity repertoire". Based on their site of origin, their 
specificity repertoire and their function, two major lymphocyte subsets can be 
assigned: the B cells and the T cells. The lymphocyte surface receptors display ligand 
binding properties, which are a reflection of their own diversity and which allow the 
collections of clonal receptors to interact with anything that can be constructed at a 
molecular level. The members of this universe of molecular structures are called 
antigens, designating the clonal collections as antigen receptors. After a lymphocyte 
has encountered an antigen it can be induced to a variety of subset-specific 
responses. Due to the rather coincidental encounter of the natural sciences with some 
of these responses the family of lymphocytes has become known as the immune 
system. Since the start of Immunology the immune system has therefore been 
considered as a host-defense machine. As a consequence of this paradigm the ability 
to distinguish endogenous self-structures from molecules of exogenous origin has 
represented the central dogma of Immunology. 
Based on the notion that it was improbable for a cellular organization like the 
immune system to have evolved from a process of selection by antigen-carrying 
intruders, Jerne indicated the importance of self-recognition for the evolutionary 
shaping and function of the immune system (1). 
Coming from a microenvironment which was rich in Jernean stimuli, this thesis 
contains a few chapters which deal with reactions of the immune system to self- and 
non-self antigens. 
Reference 
1. Jerne, N.K. 1974. Ann. J. lmmunol. (lnst. Pasteur) 125C: 373. 
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1.1 Development of B cells 
B lymphocytes are produced in hematopoietic tissues from pluripotent 
hematopoietic stem cells (1). Fetal murine B lymphopoiesis is detected earliest in the 
placenta (2) and becomes evident in the fetal liver after 13 days of gestation (3,4). After 
birth, the bone marrow becomes the major site of B cell development (5,6). After 
development to a mature stage, B lymphocytes can differentiate into cells secreting 
immunoglobulins (lg) of a unique antigen-binding specificity. lg-molecules are made 
of two heavy and two light polypeptide chains, consisting of a constant and a variable 
part. The variable regions are responsible for the antigen-binding properties of the lg-
molecule, the constant parts determine the lg-isotype. In the mouse, eight different 
isotypes (lgM, lgD, lgG1, lgG2a, lgG2b, lgG3, lgE, lgA) have been identified (7,8). 
Three gene families encode for mouse lg-chains: ~ light chain genes (9) located on 
chromosome 6, >.. light chain genes (1 0) on chromosome 16 and heavy-chain genes 
(11) on chromosome 12. During the various stages of B cell development a series of 
events occur (12) that mediate a somatic rearrangement of the lg gene clusters (13). 
During this process gene segments encoding constant regions are joined to a 
combination of the various gene segments encoding the variable region of the 
corresponding lg chain. An lg-molecule is assembled by a conjugation of two pairs 
of light and heavy chains. The multitude of genes encoding lg variable regions, the 
permutational nature of the somatic rearrangements and the putative random 
association of heavy and light chains are responsible for a highly diverse repertoire of 
different immunoglobulins (14). 
In the adult mouse 3 to 5 x 107 B cells are newly formed each day in the bone 
marrow (6). The great majority migrates to the peripheral lymphoid organs like spleen 
and lymph nodes. This production is so high that within 2-4 days enough new B 
lymphocytes are produced to replenish the whole peripheral compartment (15). A small 
proportion of the mature B cells differentiate to clones of lg-secreting cells. A total of 
1 to 2 x 106 lg-secreting cells can be found in spleen, bone marrow and lymph nodes 
(16) and about 2 x 107 secreting mostly lgA in the small intestine (17). 
References 
1. Muller-Sieburg, C.E. 1989. In: Progress in Immunology VII, ed. F. Melchers, Springer-Verlag, 
Berlin/Heidelberg, p. 331. 
2. Melchers, F. 1979. Nature 2n: 219. 
3. Raff, M.C., Megson, M., Owen, J.J.T. and Cooper, M.D. 1976. Nature 259: 224. 
4. Phillips, A.A. and Melchers, F. 1976. J. lmmunol. 117: 1099. 
5. Osmond, D.G. 1980. In: Immunoglobulin genes and B cell differentiation, eds. J.R. Battiste 
and J.L. Knight, Elsevier-North Holland, New York, p. 135. 
6. Osmond, D.G. 1986. lmmunol. Rev. 93: 103. 
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7. Edelman, G.M. 1973. Science 180: 830. 
8. Hasemann, C.A. and Capra, J.D. 1989. In: Fundamental immunology, ed. W.E. Paul, Raven 
Press, New York, p. 209. 
9. Swan, D., D'Eustachio, P., Leinwand, L., Seidman, J., Keithley, D. and Ruddle, F.H. 1979. Proc. 
Natl. Acad. Sci. USA 76: 2735. 
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17. Vander Heijden, P.J., Stok,W. and Bianchi, A.T.J. 1987. Immunology 62: 551. 
1.2 Major histocompatibility complex 
The major histocompatibility complex (MHC) is a multigene family whose 
members encode cell surface glycoproteins involved in the recognition of and in the 
immune response to antigens. The murine MHC, called the H-2 locus, is located on 
chromosome 17 (1) and contains various classes of genes (2). Two groups of 
products of the H-2 locus, the MHC class I and class II molecules, will be described 
here in some detail. 
The class I molecules, H-20, H-2K and H-2L, are highly polymorphic (3), 
consist of an H-2 encoded glycosylated polypeptide chain non-covalently associated 
with ,82-microglobulin, a small polypeptide encoded on chromosome 2, and are 
expressed on the surface of both lymphoid and non-lymphoid cells in varying densities. 
X-ray crystallographic structure determination of the human HLA-A2 molecule has 
revealed that the a3 and ,82-microglobulin domains are associated and both have the 
structure of an immunoglobulin-like domain, whereas the a1 and a2 domains form a 
symmetrical structural unit consisting of a platform composed of a ,8-pleated sheet 
topped by two a-helices with a long groove between them (4). This groove contains 
most of the polymorphic residues and provides a binding site for antigens (5). The 
class II molecules consist of two non-covalently associated peptides, an a heavy chain 
and a ,8 light chain (6) encoded by genes of the H-2 1-A and 1-E regions (7,8). A 
prediction of the three-dimensional structure of class II molecules indicated a high 
similarity with the class I molecules, including the presence of an antigen-binding 
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groove (9). 
In contrast to the class I molecules, class II molecules are constitutively 
expressed on a limited number of cell types like B cells (10,11), macrophages (12), 
interdigitating reticular cells (13) and Langerhans cells (14) and can be induced on 
several other celltypes like fibroblasts (15), endothelial cells (16), astrocytes (17) and 
thymic epithelial cells (18). 
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2. Hood, L, Steinmetz, M. and Malissen, B. 1983. Ann. Rev. lmmunoL 1: 529. 
3. Klein J., Figueroa, F. and David, C.S. 1983. Immunogenetics 17: 553. 
4. Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strominger, J.L and Wiley, D.C. 
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I mmunoL 135: 1165. 
1.3 Processing and presentation of antigens 
Structure determinations of MHC class I and class II have revealed the 
presence of a long groove in these molecules, which can bind antigen (1 ,2) and in vitro 
studies employing purified MHC molecules have shown their association with antigenic 
peptides (3-5). Before antigens can associate with MHC molecules they must be 
modified by a mechanism called antigen processing, involving their proteolytic 
degradation into small peptide fragments (6). After degradation these fragments have 
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an important role in the association of the heavy and light chains of the MHC 
molecules and their consequent transport to, and stabilisation on the cell surface {7,8). 
It is therefore supposed that all MHC molecules which are present on a cell surface, 
carry an antigenic peptide (9). There have been indications that MHC class I molecules 
associate with peptides from endogenous antigens, whereas class II molecules form 
complexes with peptides from exogenous antigens taken up by the cell (10-12), but 
this distinction is not absolute (13, 14). 
Analysis of the binding of panels of peptides to mouse 1-A d has shown the 
broad specificity of these molecules (15), which allows different peptides to compete 
for MHC-binding (16). This will lead to the presentation of a diverse set of peptides on 
each cell, including self-peptides (17). 
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1.4 Development of T cells 
The majority of T lymphocytes is produced in the thymus from hematopoietic 
precursor cells (1 ). During murine fetal development the thymus is seeded by 
precursor cells from the fetal liver in two waves, one at 10 days (2), the other at 18 
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days (3) of gestation. After birth the bone marrow becomes the source of thymic 
precursor cells (4). These are called pro-T lymphocytes (5) or prothymocytes (6). The 
thymus, an epithelial organ derived from the third and fourth pharyngeal pouches, is 
indispensable for the generation of functional T cells (7-9). It contains endo- and ecto-
dermal tissues (epithelium) as well as bone marrow derived cells (macrophages and 
dendritic cells). Anatomically, the thymus can be divided in a cortex, where most of the 
thymocytes and most of the proliferative activity can be found, and a medulla which 
contains lymphocytes with a mature phenotype (10). On the basis of the expression 
of the CD4 and CD8 surface molecules, thymocytes can be divided into four subsets. 
The double negative population, about 1 to 2% of all thymocytes, is concentrated 
under the capsule in the outer cortex, reflects the earliest stage of thymocyte 
development and has the ability to repopulate the thymus (11, 12). The double positive 
population, about 80 to 85% of all thymocytes, represents an intermediate stage of 
thymocyte development (13, 14). The remaining 10 to 15% of thymocytes compose a 
mixture of single-positive CD4 + and CD8 + cells, which are immunocompetent and 
largely found in the medulla, from where they are exported to peripheral lymphoid 
tissues. Besides CD4 and CD8, CD3 and the T cell receptor (TcR) are expressed 
during thymocyte development (15-17). Double-positive thymocytes express low-to-
intermediate levels of CD3 and TcR, whereas most single-positive cells express these 
molecules at a high level. In the mouse two types of TcR, the TcR-a.B and the TcR-ro, 
are expressed, which are composed of two chains, consisting of both constant and 
variable parts. Four gene families encode for the murine TcR-chains: a located on 
chromosome 14 (18), .B located on chromosome 6 (19), r located on chromosome 13 
(20), and o located within the a-locus on chromosome 14 (21). T cells carrying the 
TcR-ro represent a separate lineage (22), predominate in epithelia (23), and have been 
demonstrated to react to bacterial surface antigens (24,25). Their function is, however, 
still unclear and it is beyond the aim of this introduction to deal with them in more 
detail. 
During their development, thymocytes rearrange the genes encoding the TcR-
chains (26) and express the resulting receptor on their cell surface (15-17). The 
reactivity of the TcR-a.B repertoire is carefully screened by two mechanisms called 
positive and negative selection. These selections result in a population of mature 
thymocytes, which has been educated to respond to peptides presented in the context 
of self-MHC molecules and from which cells carrying receptors with a too high extent 
of autoreactivity have been deleted (27). 
Negative selection, also known as clonal deletion, prevents double positive 
thymocytes which display self-reactivity to differentiate to mature single positive T cells 
(28). Self-antigens for which clonal deletion has been demonstrated include MHC 1-E 
molecules (29,30), the minor lymphocyte stimulating antigens (MLS) (31 ,32) and the 
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male-specific HY antigen (33). Although HY is the only "conventional" antigen for which 
clonal deletion has been demonstrated, negative selection is generally considered of 
major importance for a state of immunological self-tolerance (34). 
Positive selection allows double positive cells carrying T cell receptors which 
display appropriate reactivity to self-MHC-peptide complexes to differentiate into a 
more mature stage (35,36). During positive selection interactions between MHC class 
I and CDS (37-39) and between MHC class II and CD4 (40-42) play a crucial role in the 
differentiation to mature thymocytes single-positive for CDS and CD4, respectively. 
There is some evidence that positive selection precedes clonal deletion (43) and that 
the recognition of presented self-peptides may be involved in this process (44). 
The thymus of an adult mouse releases about 1 x 106 cells each day (45). 
Experiments employing the antimitotic drug hydroxyurea have indicated that at least 
half of the peripheral T cells is constituted by lymphocytes which have divided 24-4S 
hours previously (46). These findings indicate the importance of peripheral renewal for 
the maintenance of the T cell pool, a process in which an important role for self-
peptides has recently been demonstrated (47). 
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1.5 Cellular immune responses 
Thymic development results in two major populations of T cells: COS-positive 
cells reacting with specific peptides presented in the context of MHC class I molecules 
and C04-positive cells showing MHC class II restriction {1). 
Two major functions of COS-positive cells have been demonstrated: cytotoxicity 
mediated by cytotoxic T cells (2) and suppression mediated by suppressor T cells (3). 
Cytotoxic T cells play a crucial part in the cellular immune response and have the 
ability to lyse cells presenting peptides of viral origin (4). 
"Suppressor T cells" have been defined as cells that can specifically suppress 
immune responses by antigen-specific suppressor-factors. The difficulty in cloning 
these cells, the inability to clone their suppressor-factors, the difficulty in finding their 
MHC restriction and in excluding the role of external influences on the suppression 
found in a variety of experimental systems, has made the suppressor T cell to the most 
debated and least accepted cell of the immune system. The demonstration of the 
secretion of a number of cytokines - non-antigen-specific T cell factors - by clones of 
cytotoxic cells (5), may open new ways to understand the suppressive effects 
mediated by COS-positive T cells. 
C04-positive T cells can be induced to secrete a variety of cytokines, which 
can enhance a variety of immune reactions, and are therefore known as helper T cells. 
Although the precise details are still unclear, mature C04-positive T cells are thought 
to be induced to the differentiation to the THo stage after antigen-recognition (5). From 
this stage the cells can be induced to differentiate to TH1- and TH2-cells, which are able 
to secrete distinct patterns of cytokines. These patterns, which have been established 
by the analysis of panels of helper T cell clones (6), seem to reflect the functions of the 
two subsets: TH1-cells being responsible for delayed type hypersensitivity reactions, 
producing cytokines like interleukin-2 (IL-2), interferon-r (IFN-r) and tumor necrosis 
factor; TH2-cells playing a major role in the clonal growth and differentiation of B cells, 
producing the interleukins 4, 5 and 10. 
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1.6 Humoral immune responses 
Besides the cellular immune response mediated by cytotoxic T cells, the 
humoral immune response, mediated by specific antibodies, is the second antigen-
specific mechanism by which the immune system can protect the host against 
infectious agents. Responses of B lymphocytes to most protein antigens are 
dependent upon the helper function ofT lymphocytes (1). In order to provide this 
support, CD4-positive T cells must be activated by the presentation of specific peptides 
in the context of an MHC class II molecule (2). The two functionally distinct candidates 
for antigen presentation are the antigen-specific B cell, which is ultimately stimulated 
to antibody secretion, and distinct populations of antigen-non-specific cells like 
macrophages and dendritic cells (3). The relative importance of these two classes of 
cells is highly dependent upon the concentration of antigen available for presentation, 
since it has been shown that antigen-specific B cells can effectively present antigen at 
a thousand-fold lower concentration than macrophages (4). 
After activation the helper T cells can be induced to secrete a variety of 
cytokines, which can induce antigen-specific B cells to differentiation and proliferation 
(5). As a consequence of this activation, B cells can change the isotype of the 
immunoglobulin which they synthesize from lgM to one of the other isotypes, a 
process known as isotype switching (6). It has been demonstrated that certain 
cytokines can mediate the switching to a specific isotype: interleukin-4 inducing lgGi 
and lgE, interleukin-5 inducing lgA and IFN-r inducing lgG2a (7). Cytokines can also 
inhibit the production of particular isotypes, e.g. lgE by IFN-r. During the humoral 
immune response two other processes occur which are important for host-defense: 
somatic mutation of the variable regions of the immunoglobulin molecules, causing an 
increased affinity of the antibody binding site for the antigen (8), and the generation of 
an antigen-specific memory, causing an accelerated and increased response after the 
second encounter with the same antigen (9). 
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1.7 Self, non-self and the immune system 
About a century ago the important role of the immune system in host defense 
against infectious agents was established (1). Already in the very early days of 
Immunology it was hypothesized that a host defense system should be able to make 
a fair distinction between self and non-self antigens in order to avoid a "horror 
autotoxicus" (2). Ninety years of exponentially expanded immunological research later, 
"the mechanism of self versus non-self recognition in the immune system ranks at or 
near the top of all the mysteries of modern science" (3). In order to prevent T cell 
autoreactivity, three mechanisms have been proposed (4): clonal deletion (5), causing 
a removal of autoreactive cells during thymocyte development, clonal anergy (6), 
causing a functional inactivation of mature T cells displaying autoreactivity, and 
suppression (7) mediated by self-specific suppressor cells. Clonal deletion is the only 
one of these which is currently supported by results from various in vivo studies and 
which has been demonstrated for different antigens (8-10). The demonstration of self-
reactive clones among mature lymphocytes in several experimental in vitro systems 
(11-13) has, however, indicated that T cells with autoreactive properties may be 
present in normal individuals. Mechanisms preventing the production of autoreactive 
antibodies have been documented to a lesser extent than their T cell counterparts. 
An in vivo model of double-transgenic mice, which at the one hand produce the neo 
self-antigen hen egg lysozyme and at the other hand express a high affinity antibody 
to this antigen on the B cell surface, has shown a functional silencing of these B cells 
(14). This process of silencing, however, occurred only at high antigen concentrations 
(15). The broad range of low affinity interactions with self-antigens displayed by the 
natural antibodies of unmanipulated mice (16) yet indicated that self-reactive B cells are 
present under normal physiological conditions. 
Based on the idea that the specificity repertoire of alllg is so broad that it must 
also include reactivity against antigenic sites on the variable regions of the Jg 
themselves, the so-called idiotypes, Jerne has formulated the idiotypic network theory 
(17). The results of a variety of immunization experiments have indicated the 
generation of anti-idiotypic antibodies during immune responses (18-22) and idiotypic-
connectivity has been demonstrated within the B cell pool of unmanipulated mice 
(23,24). ldiotypic interactions between BandT cells have been demonstrated (25) but 
the precise mechanisms and the relative importance of these interactions within the 
normal immune system is still unclear (26). 
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The concept of an idiotypic network has been extensively debated (26) and 
adjustments like connective networks have been proposed (27), but the central idea 
of the network theory: the active recognition of self-structures by the immune system 
(28), has not lost much of its value. A direct consequence of this network theory has 
been the proposition, that host defense is one among the tasks of the immune system, 
which could function as a kind of self-referential system (29). 
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INTRODUCTION TO THE EXPERIMENTAL WORK 
An important aspect of the idiotypic network theory (1) was the idea of an 
eigen-behaviour within the immune system, a dynamic steady state in the absence of 
antigens that do not belong to the system. This concept was an incentive to study 
the immune system of not intentionally immunized individuals. These studies have 
indicated the presence of "background" immunoglobulin secreting cells in all lymphoid 
organs of unmanipulated mice (2,3) as well as activated T cells (4). Studies on the 
kinetics of these cells indicated the high renewal rate of both background immuno-
globulin secreting cells (lgSC) (5,6) and T lymphocytes (7). The influence of exogenous 
antigenic stimulation by dietary antigens and by bacterial and viral products on the 
observed eigen-behaviour of the immune system could, however, not be excluded. In 
order to circumvent this influence, the immune system of germfree (GF) mice fed a 
chemically defined (CD) ultrafiltered diet of low molecular weight nutrients has been 
studied. These mice live under sterile conditions, are free from viruses and are fed a 
diet which can be considered free from substances with antigenic properties (8). 
Studies of the B cell compartment of these so-called GF-CD mice have been done by 
my predecessors Herbert Hooijkaas and Nico Bas (9-16). These studies indicated that 
GF-CD mice possess normal numbers of cells secreting lgM in all lymphoid tissues but 
severely reduced numbers of cells secreting other isotypes, which show a good 
correlation with the presence of these lg in the serum. lsotype switching could, 
however, be induced by in vitro culture of GF-CD B cells in the presence of the 
mitogenic substance lipopolysaccharide. Analysis of the specificity of the B cells of GF-
CD mice and their usage of lg VH genes has shown their similarity with B cells from 
conventional neonatal mice. 
Based on a report on the presence ofT cells in GF-CD mice (17), Chapter 4 
describes a study of the development of T cells in these mice. The main questions 
addressed in this chapter are: 
1. Can T cells develop in a physiological environment which has endogenous 
antigens as the only source of peptides involved in positive and negative 
selection of thymocytes? 
2. Can quantitative or qualitative differences be detected between T cell 
21 
CHAPTER 2 
development in GF-CD and conventional mice? 
3. Can quantitative or qualitative differences be detected between peripheral 
selection of T cell repertoires in GF-CD and in conventional mice? 
4. Can T cells of GF-CD mice display functional properties? 
Based on observation of severely reduced numbers of lgSC of non-lgM isotypes 
(10,13), whose isotype switching is induced by various lymphokines of helper T cell 
origin (18), Chapter 5 addresses the following questions: 
1. Can GF-CD T cells respond to allogeneic stimuli? (These responses were 
chosen since they are induced by the recognition of MHC molecules and 
associated peptides via the T cell receptor of the responding cells and thus 
allow a oirect conclusion of the functional capacity of GF-CD T cells). 
2. Can GF-CD T cells be induced to produce lymphokines? 
3. Can the factors produced by stimulated GF-CD T cells induce isotype switching 
in B cells of the same origin? 
4. Can activated T cells be detected in the peripheral lymphoid tissues of GF-CD 
mice? 
The MHC class 11 molecules are of critical importance for the intercellular 
communication between helper T cells and cells with an antigen-presenting function 
(19). Studies on the in vivo treatment of mice with specific antibodies against their 
MHC class II molecules have shown the disappearance of these molecules from the 
surface of antigen-presenting cells with a concomitant loss of antigen-presenting 
function (20,21). The extent of the effects of in vivo treatment with anti-MHC class II 
may be illustrated by the blockade found in the development of CD4-positive cells after 
an administration to neonatal mice (22,23). 
Conventional mice have background lgSC of various isotypes in their lymphoid 
organs (2,3). In order to study the mechanisms inducing B cells to this background 
secretion, Chapter 6 describes a study of the effects of in vivo treatment with anti-
MHC class II antibodies on this process. 
The following questions are addressed: 
1. Are intercellular interactions via MHC class II molecules involved . in the 
induction of background immunoglobulin production? 
2. Does treatment with anti-MHC class II antibodies affect the pool of peripheral 
T cells? 
3. Which are the kinetics of the effects of the treatment and of the subsequent 
recovery of the immune system? 
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Chapter 3 contains the protocol of the technique used in the subsequent 
chapters for the detection of lgSC. Moreover, this chapter describes a technique 
resulting from earlier studies (24,25), which allows an improved detection of cells 
secreting specific antibodies and presents results from a "classical" immunization 
study. 
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SUBSTANTIALLY INCREASED SENSITIVITY OF THE SPOT-ELISA 
FOR THE DETECTION OF ANTI-INSULIN ANTIBODY-SECRETING 
CELLS USING A CAPTURE ANTIBODY AND ENZVME-CONJUGATED 
INSULIN* 
Quirijn Vas 1, Eric Claassen2 and Robbert Benner 1 
1Department of Immunology, Erasmus University, Rotterdam 
and 2Depart~ent of Immunology, TNO, Medical Biological Laboratory, Rijswijk, 
The Netherlands 
SUMMARY 
This paper describes an antibody capture spot-ELISA for the detection of anti-
insulin antibody-secreting cells. The assay is based on the binding of secreted 
antibodies by immobilised isotype-specific capture antibodies and subsequent 
detection of insulin-specific antibodies with a conjugate of human insulin and alkaline 
phosphatase (HI-AP). Compared with the conventional approach, using antigen for 
coating and employing an enzyme-linked detecting antibody, this technique improved 
the detection of cells secreting anti-insulin antibodies of the lgG-isotypes. 
INTRODUCTION 
Two types of assays can be used to enumerate antibody-secreting cells (ASC), 
namely haemolytic (Jerne and Nordin, 1963; Gronowicz et al., 1976) and reverse 
haemolytic (Eby et al., 1975) plaque assays and secondly, spot-ELISA (Sedgwick and 
Holt, 1983; Czerkinsky et al., 1983). 
*Published in: J. lmmunol. Methods. 1990. 126: 89. 
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Haemolytic plaque assay is limited by difficulties in coupling certain antigens 
to red cells (Golub et al., 1968; Pasanen and Makela, 1969), instability of the products 
and the inability to determine the isotype of antibody contributing to direct plaque 
formation (Wortis et al., 1969). The sandwich spot-ELISA is more flexible and has been 
used for the simultaneous detection of distinct types of ASC (Czerkinsky et al., 1988b), 
enumeration of lymphokine producing lymphocytes (Czerkinsky et al., 1988a; 
Versteegen et al., 1988) and a variety of studies (Holt et al., 1984; Logtenberg et al., 
1986; Bos et al., 1988; Zigterman et al., 1988). 
In order to study the murine immune response to insulin we decided to develop 
a sandwich spot-ELISA for anti-insulin ASC, but found difficulty in detecting ASC of the 
lgG-isotypes. We adopted an antibody capture alternative approach {Clark and Adams, 
1977; Crook and Payne, 1980; Vos and Benner, 1989) using a new method for 
coupling proteins to alkaline phosphatase (Claassen and Adler, 1988) to resolve the 
problem. This spot-ELISA allowed improved detection of cells secreting anti-insulin 
antibodies of the lgG-isotypes. 
MATERIALS AND METHODS 
Reagents 
2-amino-2-methyl-1-propanol {AMP), alkaline phosphatase {AP), 5-bromo-4-
chloro-3-indolyl phosphate (5-BCIP), bovine serum albumin (BSA), glutaraldehyde 
(GA), lysine HCI and p-nitrophenyl phosphate were obtained from Sigma Chemical Co., 
St. Louis, MO. lsotype-specific goat anti-mouse (GAM) lg antisera and antiserum 
alkaline phosphatase conjugates {GAM-AP) were from Southern Biotechnology, 
Birmingham, AL. Human semisynthetic monocomponent insulin (HI) was obtained from 
Novo Biolabs, Bagsvaerd, Denmark. Complete Freund's adjuvant (CFA) was from 
Difco, Detroit, MI. Glycerol and Tween 20 were from Merck, Darmstadt, F.R.G .. RPM I 
1640 culture medium was from Gibco, Glasgow, Scotland. Monoclonal rat anti-mouse 
~-light-chain (RAM-~) {Yelton et al., 1981) and monoclonal mouse lgG1/~ anti-insulin 
p.10 (Vos and Benner, 1989) were purified by affinity chromatography. The protein 
content was determined by spectrophotometry at 280 nm. 
Preparation of enzyme-conjugated insulin 
A conjugate of HI and AP was prepared according to Claassen and Adler 
(1988). 5 mg AP were dissolved in 2 ml phosphate-buffered saline (PBS) and 
extensively dialysed against PBS. Next GA was added to the dialysis fluid to a 
26 
Spot-ELISA for anti-insulin antibody-secreting cells 
concentration of 0.2% and incubated overnight at 4 ° C. Excess GA was removed by 
dialysis of the reaction mixture against PBS and the activated AP was transferred to 
a test tube containing a solution of 5 mg HI in 4 ml PBS. After overnight incubation at 
4 oc, 0.25 ml 0.2 M lysine HCI were added, the mixture was incubated for 2 h at room 
temperature, purified by dialysis against PBS, filter-sterilized, diluted 1:1 with glycerol, 
and stored at -20°C. 
Immunization of mice 
Male BALB/c mice, 16 weeks of age, were immunized with 20 J,Lg HI in 50 J.Ll 
of an emulsion of PBS/CFA (1:1) in both rear footpads according to Schroer et al. 
(1979). 
Preparation of cell suspensions 
Cell suspensions from popliteal lymph nodes (PLN) were prepared as 
described by Benner et al. (1981). Concentrations of PLN cells and p.10 hybridoma 
cells 0fos and Benner, 1989) were determined with a Coulter Counter (Coulter 
Electronics, Luton, U.K.). 
Sandwich ELISA 
96 well plates (fitertek no. 77-172-05, Flow Laboratories, Zwanenburg, The 
Netherlands) were coated with 100 J.LI of a 10 J,Lgjml solution of HI in PBS by incubating 
for 1 hat 37"C. Next the plates were postcoated by adding 100 J.LI of PBS containing 
1% BSA and 0.1% Tween 20 (PBT 1.0) to each well and incubating for 0.5 h at 37" C. 
After postcoating the plates were incubated with 1 00 J,Ll of different concentrations of 
monoclonal antibody (MAb) p.10 in PBT 1.0. After 1 h of incubation at 37"C and three 
washes with PBS containing 0.1% BSA and 0.1% Tween 20 (PBT 0.1), 100 J.LI of a 
1/1000 dilution of GAM-IgG1-AP in PBT 1.0 were added, after which the plates were 
incubated for 1 h at 37 ° C. After five washes with PBT 0.1, 100 J.Ll of substrate solution 
containing 0.2% PNP in AMP buffer (Sedgwick and Holt, 1983) were added. After 1 h 
of incubation at 37" C extinctions were determined spectrophotometrically (Titertek, 
Multiscan, Flow Laboratories, Irvine, U.K.). 
Antibody capture ELISA 
96 well plates were coated with 100 J,LI of a solution containing 10 J,Lgjml of 
GAM-IgG1 in PBS. Next the plates were treated according to the sandwich ELISA 
protocol with exception of the detection of the MAb, for which 100 J,Ll of a 1 :100 dilution 
of HI-AP in PBT 1.0 were used instead of GAM-IgG1-AP. 
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Sandwich spot-ELISA 
96 well plates were coated with 100 J.£1 of a solution of 10 J,Lgjml of HI in PBS 
by incubation for 1 hat 37"C. Next the plates were postcoated by adding 100 J.LI RPMI 
1640 containing 1% BSA to each well and incubating for 0.5 h at 37"C. After 
postcoating, 100 J.LI of cell suspensions of different concentrations in RPMI 1640 
containing 1% BSA were added and the plates were incubated for 6 hat 37"C in a 
vibration-free, 5% C02 incubator. Next the plates were washed three times with PBT 
0.1 and 100 J.LI of a 1:1000 dilution of GAM-AP in PBT 1.0 were added to each well, 
after which the plates were incubated overnight at room temperature. After five washes 
with PBT 0.1, 100 J.LI of substrate solution containing 0.1% 5-BCIP in AMP buffer were 
added. After 1 h of incubation at 37"C the supernatants were discarded and the plates 
were washed three times with distilled water. The spots, identifiable by disposition of 
insoluble enzyme reaction product, were counted using a colony viewer (Bellco Glass, 
Vineland, NJ). 
Antibody capture spot-ELISA 
96 well plates were coated with 100 J.LI of solutions containing 10 J,Lgjml GAM 
or rat anti-mouse K. (RAM-K.) in PBS. Next the plates were treated according to the 
sandwich spot-ELISA protocol except for the detection of secreted lg. Here plates 
coated with GAM received 100 J.LI of a 1 /50 dilution of HI-AP in PBT 1.0 for detecti~n 
of anti-insulin ASC, whereas plates coated with RAM-K. and incubated with 100 J.LI of a 
1/1000 dilution of GAM-IgG1-AP in PST 1.0 were used to detect lgG1 lgSC. 
RESULTS 
In order to improve a sandwich spot-ELISA for anti-insulin ASC, which used HI 
for coating and GAM-AP for antibody detection, a spot-ELISA employing capture 
antibodies was developed. To detect insulin binding, a conjugate of HI and AP was 
prepared according to a method (Claassen and Adler, 1988) that ensured a minimal 
change in the immunogenic structure of the insulin molecule. An ELISA was used to 
compare the sensitivity of the capture-coating system with the sensitivity of the antigen-
coating system. Fig. 1 shows the results from this comparison for the lgG1/K. anti-
insulin MAb p.10. Both titration curves show that the capture-system was approximate-
ly 25 times more sensitive than the system that employed antigen for coating. Results 
from the analysis of a panel of other anti-insulin MAb showed improvements of 
sensitivity that ranged from 10 to 100 times (data not shown). 
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Figure 1. Titration curves of anti-insulin MAb p.1 0 
by two types of ELISA o : Plates were coated with 
HI and titrated with purified MAb. The detector anti-
body was GAM-IgG 1-AP. • : Plates were coated with 
GAM-IgG1 and titrated with purified MAb. HI-AP was 
used for detection. 
Based on these results, the capture system was employed in an antibody 
capture spot-ELISA Fig. 2 shows results from three types of spot-ELISA for p.10 
hybridoma cells. Secretion of immunoglobulins was assayed by a system using RAM-~~; 
for coating, and GAM-IgG1-AP for detection. 
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Figure 2. Spot-ELISA of p.1 0 anti-insulin hybridoma cells. A: detection of immunoglobulin secretion. 
Plates were coated with RAM-~~; and various concentrations of cells were added. The detector antibody 
was GAM-IgG1-AP. 8: detection of anti-insulin ASC. o: plates were coated with HI and cells were added 
in different concentrations. The detector antibody was GAM-IgG1-AP. •: plates were coated with GAM-
IgG1 and various concentrations of cells were added. HI-AP was used for detection. Results are 
expressed as mean numbers± SD (n=8). 
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Fig. 2A shows that this system detected immunoglobulin-secretion in 50% of the 
hybridoma cells. Fig. 28 shows the relative sensitivity of detection of HI-specific ASC 
by the sandwich and antibody capture spot-ELISAs. The data show that the antibody 
capture spot-ELISA detected approximately 75% of the immunoglobulin (lgSC), 
whereas the sandwich spot-ELISA, detected only 5%. Results from the analysis of a 
panel of anti-insulin hybridomas of lgG1 and lgG2 isotypes confirmed these 
percentages (data not shown). 
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Figure 3. Kinetics of the primary anti-insulin ASC response in the popliteal lymph nodes of mice 
immunized with HI. Detection of ASC with two types of spot-ELISA. A: lgM ASC. B: lgG1 ASC. C: lgG2a 
ASC. D: lgG3 ASC. o : plates were coated with HI and cells were added in different concentrations. The 
detector antibody was GAM-AP against the various isotypes. o : plates were coated with GAM against 
the various isotypes and different concentrations of cells were added. HI-AP was used for detection. 
Results are expressed as geometric mean± S.E.M. (n=3). During the first five days of the response no 
anti-insulin ASC could be detected. Results lower than 1 ASC/106 PLN-cells are not shown. 
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To test the new method on a polyclonal population of anti-insulin ASC, BALB j c 
mice were immunized with HI in CFA in both rear footpads. Popliteal lymph node (PLN) 
cells were isolated at various days after immunization and assayed for anti-insulin ASC. 
Fig. 3 shows the kinetics of the anti-insulin ASC response of the lgM, lgG1, lgG2a and 
lgG2b isotypes assayed by the sandwich and the antibody capture spot-ELISA. These 
results illustrate the improvements that the use of a coating of capture antibodies and 
detection of secreted antibodies with an antigen-AP conjugate may bring on the 
conventional spot-ELISA for the detection of ASC of the lgG isotypes. 
DISCUSSION 
This paper describes a spot-ELISA for anti-insulin ASC. The use of capture 
antibodies to bind secreted antibodies and HI-AP to detect insulin binding resulted in 
a spot-ELISA with an improved sensitivity of ASC of the lgG isotypes. This improve-
ment may be explained by an increase in the avidity of the plate-binding interaction, 
which will be greater for a dimeric lgG molecule than for a pentameric lgM. Moreover 
the sensitivity of the conventional spot-ELISA for lgM ASC may be attributed to the size 
of the lgM molecule, which can be simultaneously bound by a number of enzyme-
linked second antibody-molecules. 
The quality of the antigen-AP conjugate is crucial in the performance of the 
spot-ELISA based on capture antibodies. The conjugation method we used mildly 
activates the AP using glutaraldehyde (GA), resulting in a minimal inactivation and 
intermolecular crosslinking of the enzyme molecule. After removing excess of GA the 
antigen is conjugated under conditions of neutral pH and low salt concentration without 
the presence of organic solvents. These conditions make this method applicable for 
a large variety of protein-antigens. 
The use of capture antibodies for coating allows this spot-ELISA to be 
employed for the enumeration of ASC of different antibody isotypes of various species. 
In order to have an optimal binding of secreted antibodies, the capture antibody should 
be as pure as possible. Purified MAb or affinity purified polyclonal antibodies are most 
suitable for this purpose. If a choice is to be made between different antibody 
preparations, an ELISA similar to the one described in Fig. 1 may be useful for 
performance testing. 
The use of this spot-ELISA may facilitate studies of isotype-switching and other 
aspects of the kinetics of immune responses. Simultaneous detection of cells secreting 
antibodies of different specificities is another possibility of this spot-ELISA. 
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SUMMARY 
The influence of exogenous antigenic stimulation on the development ofT cells 
and the selection of their repertoire was investigated. For this purpose germfree 
BALB/c mice fed an ultrafiltered solution of chemically defined low molecular weight 
nutrients (GF-CD) were used. A comparison of the various lymphocyte populations in 
the thymus, lymph nodes and spleen from GF-CD and conventional mice using flow 
cytometry analysis revealed no significant differences. Flow cytometry analysis of the 
T cell receptor (TcR) V/3 expression on both mature thymocytes and lymph node T 
cells showed no differences between GF-CD and conventional mice. This stands in 
clear contrast to the B cell compartment, since the B cell repertoire of GF-CD mice has 
previously found to differ substantially from that of conventional mice. Activation of 
GF-CD splenic T cells by crosslinking with monoclonal antibodies (MAb) against TcR-
a/3 resulted in proliferation both with and without addition of exogenous sources of 
lymphokines. These findings demonstrate that functional T cells develop in mice that 
have not been exposed to exogenous antigens and that the TcR repertoire, in contrast 
to the B cell compartment, is generated autonomously. 
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INTRODUCTION 
T cells expressing TcR-aP recognize antigens presented in the context of self-
major histocompatibility complex (MHC) molecules [1 ,2]. Since the TcR is generated 
by random rearrangement of DNA segments [3], the TcR repertoire must be shaped 
for appropriate MHC restriction and antigenic specificity. This process involves positive 
[ 4-12] and negative [13-19] selection in the thymus, both requiring interactions 
between TcR, MHC and accessory molecules like CD4 and CDS. The mature 
thymocytes evolving from these selective pressures can enter the periphery to display 
reactivity against non-self and tolerance to self antigens. 
GF-CD mice have been used to study several aspects of B cell development 
and function in the absence of exogenous antigenic stimulation [20-27]. These studies 
showed that GF-CD mice had normal levels of serum lgM, but severely reduced levels 
of the other immunoglobulin (lg) isotypes and corresponding frequencies of lg 
secreting cells (lgSC) in spleen, lymph nodes and bone marrow. Moreover the usage 
of the lg V H-genes in hybridoma collections of adult GF-CD mice was found to be 
restricted and to resemble the repertoire of conventional neonatal mice, which :s clearly 
different from the repertoire in adult conventional mice (26). 
Based on a report on the presence ofT cells in the peripheral lymphoid organs 
of GF-CD mice [28], we have investigated the development of T cells in animals free 
from exogenous antigenic stimulation. We have performed flow cytometry analysis on 
cells in thymus, lymph nodes and spleen of GF-CD mice and of expression of TcR-
VP chains on mature thymocytes and lymph node T cells. Our findings suggest that 
the T cell repertoire of GF-CD mice, in contrast to the B cell repertoire, is similar to that 
of conventional mice. The proliferation of peripheral GF-CD T cells induced by TcR 
crosslinking indicated their functionality. 
MATERIALS AND METHODS 
Mice 
GF-CD BALB/c mice, 8 to 10 weeks of age, were purchased from American 
Biogenetic Sciences (Notre Dame, IN). These mice were reared and maintained 
germfree in the Lobund Laboratory (University of Notre Dame, Notre Dame, IN) and 
fed a chemically defined ultrafiltered diet of low molecular weight nutrients consisting 
of L489-E14 Se and LADEK 69E6 [29]. Age-matched conventional BALB/c mice were 
obtained from the National Cancer Institute (Frederick, MD). 
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Preparation of cell suspensions 
Suspensions of mature thymocytes were prepared as described previously 
[6,30]. Suspensions of purified splenic and lymph node T cells were prepared using 
anti A/ (MK-D6) [31] and anti Ec/ (14-4-4) [32] according to the same protocol. 
Detection of lgSC 
Splenic background lgSC in GF-CD and conventional mice were detected with 
the enzyme-linked immunosorbent assay (ELISA) plaque test [33] with some 
modifications described previously [34]. 
Flow cytometry 
Cell suspensions were prepared in HBSS (without phenol red) containing 1% 
BSA and 0.1% sodium azide. Cells (106 /100 J.LI buffer) were incubated on ice for 30 min 
with 10 J.£1 of the appropriate antibody, and washed twice after each incubation. Control 
staining of cells with irrelevant antibody was used to obtain background fluorescence 
values. The samples were analyzed on a FACS 440 (Becton Dickinson & Co., 
Mountain View, CA) interfaced to a PDP 11/24 computer, as previously described [4]. 
Data were collected on 50,000 cells. Reagents used for direct staining were FITC- or 
biotin conjugated anti: CD3 (2C11) [35], CD4 (GK 1.5) [36], CD5 (53-7.3) [37], CDS 
(2.43) [38], TcR-a.B (H57-597) [39], V.B3 (KJ25a) [40], V.B5.1,5.2 (MR9-4) [41], V.B6 
(RR4-7) [42], V,88.1,8.2 (KJ16-133) [43,44], V,88.1,8.2,8.3 (F23.1) [47,48], V.811 (RR3-
15) [46], l-Ad (MK-D6) [31], l-Ed (14-4-4) [32] and lgM (Becton Dickinson & Co.). Anti 
J11 D [48] was used for indirect staining, employing anti-rat lgG as described [49]. 
T cell proliferation assay 
For MAb induced T cell proliferation purified anti-TcR-a.B (H57-597) [39] was 
diluted in PBS and 30 JLI of solutions of various concentrations were added per round 
bottom microtiter well. Plates were incubated for 2 hours at 37"C and then washed 3 
times with PBS before use. 2 x 105 T cell-enriched spleen cells in 200 JLI complete 
DMEM (10% FCS, 5 x 10-5 M2-ME, 10 mM Hepes, 200 mM glutamine, 1 mM sodium 
pyruvate, 10 Ujml penicillin and 100 JLgjml streptomycin) were added per well. Where 
indicated, recombinant human interleukin-2 (IL-2) was added at a final concentration 
of 10 Ujml. After 48 hours, cultures were pulsed with 1 JLCi of [3H]-thymidine and 
harvested 18 hours later. Values represent the arithmetic mean of triplicate cultures. 
Standard errors were generally less than 10% of the mean. 
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RESULTS 
Frequencies of splenic background lgSC from GF-CD and conventional mice 
Before considering the T cell development in the GF-CD mice, we confirmed 
earlier results on the B cell compartment in GF-CD mice. The frequencies of splenic 
background lgSC of various isotypes were determined employing the ELISA-plaque 
test (Fig. 1). As previously reported [20,24], the GF-CD mice had normal frequencies 
of lgM-SC, but highly reduced numbers of cells secreting the other isotypes. Thus, the 
B cell compartment is severely affected by the absence of exogenous antigens. 
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Figure 1. Frequency of background lgSC of various isotypes in the spleens of GF-CD (solid columns) 
and conventional mice (open columns). The data are expressed as the geometric mean of three 
individually tested animals ± SEM. 
Comparison of thymocyte populations from GF-CD and conventional mice 
Table 1 summarizes the results from the flow cytometry analysis of thymocyte 
populations of GF-CD and conventional mice. The GF-CD mice had similar numbers 
of CD4 and CDS single-positive thymocytes as well as of double-positive and double-
negative cells as conventional mice. Analysis with anti-CD5 also indicated no significant 
differences among the major thymocyte populations [50]. The staining of thymocytes 
from GF-CD and conventional mice for the HSA marker indicated comparable 
frequencies of immature J11D+ cells [55]. Staining with anti-TcR, -CD4 and -CDS 
yielded similar results for both GF-CD and conventional mice as did the analysis with 
3S 
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anti-TcR and anti-C03, with the population of CD3+TcR-a,8- cells representing the 
population of TcR--yo+ thymocytes. 
TABLE 1. Flow cytometry analysis of lymphocyte populations in the thymus of GF-CD and 
conventional mice 
Population GF-CD Conventional 
-
CD4+Co8+ 73.1 76.8 
CD4+Co8· 11.9 10.7 
CD4-CD8+ 4.3 5.9 
CD4"CD8- 10.7 6.7 
CD8+cos+ 80.8 79.9 
co8·cos+ 12.0 11.9 
J11D+CD4+ 73.8 71.1 
J11D+co8+ 65.4 68.0 
CD4+TcR-ap+ 14.3 14.9 
CD4+TcR-a,8· 74.6 77.1 
CD8+TcR-a,8+ 8.0 7.8 
CD8+TcR-a,8· 74.0 76.6 
CD3 +TcR-a,B· 2.4 2.0 
Numbers represent the percentages of positive cells and are representative of 3 separate experiments 
with pooled thymuses from 3 or 4 mice. 
In order to study the repertoire of TcR V,B chains expressed on the mature 
thymocytes, thymic cell suspensions were enriched for single-positive T cells by 
treatment with anti-J11 D MAb and complement. The resulting populations from both 
GF-CD and conventional mice were analyzed for V,B expression with a panel of MAb 
specific for different TcR V,B chains. The data of this analysis are summarized in Table 
2. The analysis indicates no significant differences between the repertoires of mature 
thymocytes of GF-CD and conventional mice. The reduced percentages of cells with 
V,83, V,85 and V,811 indicate that GF-CD thymocytes are subject to a normal clonal 
deletion for reactivity with superantigens [40] and peptides in association with EaE,B 
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[45,46], respectively. 
TABLE 2. Flow cytometry analysis of TcR-Vj:l expression on mature thymocytes from GF-CD and 
conventional mice 
GF-CD Conventional 
TcR CD4+ cos+ CD4+ cos+ 
Vj:l2 10.0a 4.4b 12.9 6.7 
Vj:l3 0.3 0.0 0.4 O.S 
Vj:l5.1 0.7 0.7 0.6 0.0 
Vj:l5.1 +5.2 0.4 1.3 0.6 0.4 
Vj:l6 7.1 7.6 6.4 5.7 
Vj:IS.1+S.2 32.4 22.2 39.S 26.5 
Vj:IS.1 +S.2+S.3 34.0 32.1 39.1 37.4 
Vj:l11 0.5 1.0 1.3 0.0 
a. Numbers represent percentages of the population of mature thymocytes carrying CD4 and 
TcR-aj:l and are representative of 3 separate experiments with pooled thymuses from 3 or 4 
mice. Enrichment was obtained by treatment with J11 D plus complement as described [6]. 
b. Numbers represent percentages of the population of mature thymocytes carrying TcR-aj:l and 
negative for CD4; reciprocal staining confirmed the CDS phenotype of these cells. 
Comparison of lymph node cell populations from GF-CD and conventional mice 
Table 3 shows the results from a flow cytometry analysis of lymph node cells 
from GF-CD and conventional mice. The distribution of CD4 +, CDS+ and CD3 + T 
cells and surface lg (slg) positive B cells were very similar as were the percentages of 
I-A and 1-E bearing cells. For the analysis of the TcR V J:1 chain expression, lymph node 
cells were treated with a mixture of anti-AJ:I and anti-Ea MAbs and complement and 
were stained according to the same protocol as the mature thymocytes. The resulting 
data are summarized in Table 4. The results indicate a high degree of similarity 
between the VJ:! repertoires of the lymph node T cells of GF-CD and conventional mice. 
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TABLE 3. Flow cytometry analysis of lymphocyte populations in lymph nodes from GF-CD and 
conventional mice 
Population 
CD4 
CDS 
slg 
I-A 
1-E 
GF-CD 
44.7 
1S.1 
3S.2 
34.9 
20.9 
Conventional 
46.2 
19.0 
34.3 
34.2 
19.4 
Numbers in the columns represent the percentage of positive cells and are representative of 3 separate 
experiments with pooled lymph nodes from 3-4 mice. 
TABLE 4. Flow cytometry analysis of TcR-V.B expression on purified lymph node T cells from GF-
CD and conventional mice 
GF-CD Conventional 
TcR CD4+ cos+ CD4+ cos+ 
V,82 6.9a s.sb 6.S 7.5 
V,83 0.3 0.6 0.3 0.7 
V,85.1 0.2 2.7 0.3 3.0 
V,85.1 +5.2 0.3 3.2 0.2 3.1 
V,86 12.0 14.2 12.3 14.7 
V,BS.1 +S.2 11.5 15.2 11.6 13.7 
V,88.1 +8.2+8.3 18.3 30.8 19.9 29.0 
V,811 0.2 2.1 0.3 2.6 
a. Numbers represent percentages from the population of purified T cells carrying CD4 and TcR-
a.,B; T cells were purified by treatment with anti-A8 and anti-E" plus complement as described 
and collected from pooled lymph nodes from 3 mice. 
b. Numbers represent percentages from the population of purified T cells carrying TcR-a.B and 
negative for CD4; reciprocal staining confirmed the CDS phenotype of these cells. 
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Comparison of splenic cell populations from GF-CD and conventional mice 
Table 5 shows the results from a flow cytometry analysis of splenocytes from 
GF-CD and conventional mice. The data again indicate no significant differences and 
confirm the presence of MHC class II molecules on a fraction of the GF-CD 
lymphocytes. 
TABLE 5. 
Population 
-
CD4 
CDS 
slg 
I-A 
1-E 
Flow cytometry analysis of splenic lymphocyte population from GF-CD and 
conventional mice 
GF-CD Conventional 
31.8 27.6 
14.9 13.3 
49.4 46.2 
46.6 45.6 
32.2 34.8 
Numbers in the columns represent the percentages of positive cells and are representative of 3 separate 
experiments with pooled spleens from 3 or 4 mice. 
In vitro activation of splenocytes from conventional and GF-CD mice 
The previous data indicated the presence of normal frequencies of T cells in 
the peripheral lymphoid organs of the GF-CD mice and a normal TcR Vft repertoire. 
In order to investigate whether these T cells were also functional, spleen cells were 
stimulated in vitro by MAb against TcR-aft with or without the addition of IL-2. Fig. 2 
shows the results from the stimulation of purified splenic T cells from both GF-CD and 
conventional mice. The data indicate that the splenic T cells were induced to 
proliferation by TcR crosslinking, showing that GF-CD mice had functional peripheral 
Tcells. 
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Thymocytes 
withoutll:2 withll:2 
2x1QS 
1 X 1()5 
0 
E 0.1 1.0 10 0.1 1.0 10 
0.. 
0 Splenocytes 
withoutll:2 with IL-2 
I 
3x 10S 
2x 10S 
1 X 1()5 
Q.L......-.l..-
0.1 1.0 10 0.1 1.0 10 
antibody coating concentration (Jig/ml) 
Figure 2. In vitro stimulation of purified splenic T cells from GF-CD (solid columns) and conventional 
mice (open columns). 2 x 105 T cell enriched spleen cells were cultured in presence or absence of 
added IL-2 in microtiter wells coated with various concentrations of anti-TcR-a:.B antibodies. 
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DISCUSSION 
In this paper we have investigated the development ofT cells in mice that had 
never been exposed to exogenous antigenic stimulation. This implies that endogenous 
self-antigens were the only source of MHC bound peptides [52] involved in both thymic 
development and peripheral T cell selection. Previous data on the development of B 
cells in GF-CD mice have shown that the frequency of lgSC of non-lgM isotypes was 
highly reduced. These findings suggest that the T cell repertoire is shaped in such a 
way by negative selection, that mature T cells cannot be induced by endogenous 
antigens to secrete T cell factors that can induce isotype switching [53] in B cells. 
The presence of functional T cells in the spleen and lymph nodes of GF-CD 
mice supports evidence from radiation chimaera experiments on the role of self-
peptides in positively selecting the T cell repertoire [54]. 
From this and the demonstration of MHC class II molecules on lymphocytes 
in the peripheral lymphoid organs it could be speculated that functional T cells indeed 
recognize the presented self-peptides, but that thymic selection has shaped their 
repertoire in such a way that these encounters do not induce differentiation into THo 
cells [55] capable of producing interferon r and interleukin 4. 
The high extent of similarity between the V/3 repertoires of mature thymocytes 
from GF-CD and conventional mice and especially the equal presence of cells carrying 
V/38.1 ,8.2 and 8.3 indicate [56] that exogenous superantigens like staphylococcal 
enterotoxin B only have a marginal influence on the selection of the T cell repertoire. 
The results from this V/3 repertoire analysis, however, do not allow a definitive 
conclusion on the similarity between TcR repertoires of GF-CD and conventional mice. 
For this purpose a thorough analysis of theN-junctional diversity in the TcR repertoire 
of these mice should be performed, since this mechanism of TcR gene assembly is of 
great importance for the generation of a diverse TcR-repertoire (57). 
Based on the analysis of the size distribution of T and B lymphocytes it has 
been concluded [28] that GF-CD mice possess activated T and B cells. The question 
of the state of activation of peripheral T cells in GF-CD mice is of great importance for 
our understanding of T cell function in GF-CD and conventional animals. Our results 
allow no direct answer to this question and we believe that supplementary experiments 
need to be performed to conclude the presence of activated T cells in GF-CD mice. 
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AUTONOMOUS T CELL ACTIVATION IN GERMFREE MICE FED A 
CHEMICALLY DEFINED LOW MOLECULAR ULTRAFILTERED DIET 
Quirijn Vas 1, Lori A. Jones2 and Ada M. Kruisbeek2 
1Department of Immunology, Erasmus University, Rotterdam, The Netherlands and 28iological 
Response Modifiers Program, National Cancer Institute, National Institutes of Health, 
Bethesda, Maryland 20892 
SUMMARY 
Germfree mice fed a chemically defined low molecular weight ultrafiltered diet 
(GF-CD) were used to study the functionality of T cells generated in an environment 
free from exogenous antigenic stimulation. Results from mixed lymphocyte cultures and 
antibody mediated T cell receptor crosslinking indicated that GF-CD T cells were 
capable of mounting normal all a reactive responses and of secreting lymphokines that 
could induce isotype switching in GF-CD B cells. Flow cytometry analysis indicated the 
presence of the IL-2 receptor on GF-CD splenic T cells. Limiting dilution analysis of 
purified GF-CD splenic T cells indicated the presence of the high affinity IL-2 receptor, 
suggesting the presence of activated T cells. The significance of these findings for the 
internal activity of the normal immune system and its function are discussed. 
INTRODUCTION 
The immune system is indispensable in the defense of the vertebrate host to 
a variety of infectious agents. By defining the immune system as a host defense 
machinery against non-self, the distinction between self and non-self becomes a main 
feature of its function. To prevent a "horror autotoxicus" (1 ), a state of self-tolerance 
should be maintained. Three mechanisms have been proposed (2) preventing T cell 
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autoreactivity: clonal deletion (3), clonal anergy (4) and suppression (5). Autoimmunity 
is generally considered to be caused by a failure of one or more of these mechanisms 
(6). The demonstration of selfreactive clones among mature lymphocytes in several 
experimental in vitro systems (7-9), however, suggests that T cells with autoreactive 
properties may be present in the peripheral organs of animals not suffering from 
autoimmune disorders. These findings support hypotheses that self-recognition is 
essential within the immune system (1 0-11) and that host-defense is a function of the 
immune system, but not its "raison d'@tre" (12,13). 
Studies using non-intentionally immunized animals have indicated background 
activity in the immune system (14, 15), but cannot exclude the influence of bacteria, 
viruses and other causes of exogenous antigenic stimulation on these results. The 
availability of germfree mice fed a chemically defined ultrafiltered low molecular weight 
diet (GF-CD) offers the opportunity to study the immune system of animals that have 
lived in the complete absence of exogenous antigenic stimulation. Studies on the B cell 
development in GF-CD mice (16-19) have shown a highly reduced number of cells 
secreting immunoglobulins (lg) of the non-lgM isotypes, a restricted use of lg-VH 
genes and a high extent of multireactivity within the pool of lipopolysaccharide (LPS)-
reactive B cells. Studies on the development ofT cells in GF-CD mice (20,21) have 
indicated a normal incidence and repertoire of mature thymocytes and a normal 
repertoire of non-anergic peripheral T cells. In the present study we have investigated 
the functional properties of peripheral T cells from GF-CD mice, showing their ability 
to mount allogeneic responses and to produce lymphokines that could induce isotype 
switching in GF-CD B cells. Using flow cytometry analysis the interleukin 2 receptor (IL-
2R) could be detected on a significant part of splenic GF-CD T cells. Limiting dilution 
analysis of GF-CD splenic T cells on IL-2 indicated the presence of cells carrying the 
high affinity IL-2R. These findings suggest the presence of activated T cells in GF-CD 
mice and support hypotheses on an autonomous activation of the immune system. 
MATERIALS AND METHODS 
Mice 
GF-CD BALB/c mice, 8 to 10 weeks of age, were purchased from American 
Biogenetic Sciences (Notre Dame, IN). These mice were reared and maintained 
germfree in the Lobund Laboratory (University of Notre Dame, Notre Dame, IN) and 
fed a chemically defined ultrafiltered diet of low molecular weight nutrients consisting 
of L489-E14 Se and LADEK 69E6 (22). Age-matched specific pathogen free (SPF) 
BALB/c mice and conventional BALB/c, C57BL/6, C3H and DBA/2 mice were 
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obtained from the National Cancer Institute (Frederick, MD). 
Tissue culture medium 
DMEM supplemented with penicillin at 10 Ujml, streptomycin at 100 JLgfml, 
10 mM Hepes, 2 mM L-glutamine, 1 mM sodium pyruvate, 50 JLM 2-mercaptoethanol 
and 10% heat inactivated fetal calf serum was used for all cell cultures. 
T cell purification 
T cells were purified from splenocyte suspensions by treatment with anti-Ap d' 
MK-06 (23), anti-Ec/, 14-4-4 (24) and complement. 
Mixed lymphocyte culture 
The indicated number of purified splenic T cells were incubated with 5 x 105 
irradiated (2000 rads) spleen cells in 96-well flat-bottom microtiter plates. After 3 days, 
cultures were pulsed with 1 JLCi of [3H]-thymidine and harvested 18 hours later. All 
determinations were performed in triplicate. Data are expressed as Acpm i.e., cpm 
values of experimental groups minus responder cells alone. 
In vitro stimulation with anti-CD3 
15 ml culture flasks were coated with 50 JLgfml purified anti-CD3, 2C11 (25) 
in PBS by incubation for 2 hours at 37"C and washed once with tissue culture medium. 
Next 2 x 107 splenocytes in 2 ml medium were added to anti-CD3 or control (PBS 
coated flasks) and incubated for the indicated time. After culture, cells were removed 
and counted with a hemocytometer. 
ELISA spot assays 
lnterferon--y (IFN--y) secreting cells were detected as described (26), 
lg-secreting cells (lgSC) of various isotypes according to Sedgwick and Holt (27) with 
some modifications (28). 
Flow cytometry analysis 
Cell suspensions were prepared and analysed as described previously (29). 
Reagents used for staining were fluorescein isothiocyanate-conjugated anti-IL-2R, 
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PC.61 (30), biotin-conjugated anti-CD4, GK 1.5 (31 ), and anti-T cell receptor(TcR)-a.B, 
H57-597 (32). 
limiting dilution analysis of high affinity ll-2R expression 
Multiple cultures of various concentrations of purified splenic T cells were 
cultured in 96-well round bottom microtiter plates with or without the addition of IL-2 
at a final concentration of 10 U/ml. After 3 days, cultures were pulsed with 1 JLCi of 
eH]-thymidine and harvested 18 hours later. Cultures containing IL-2 were scored 
positive if their counts exceeded the arithmetic mean plus 3 SD of cultures of corre-
sponding numbers of cells grown in the absence of IL-2. 
RESULTS 
Mixed lymphocyte cultures of GF-CD splenic T cells 
In order to investigate the response of GF-CD T cells to a stimulus involving 
TcR mediated recognition of major histocompatibility complex (MHC) molecules and 
associated antigens, BALBjc GF-CD splenic T cells were stimulated with allogeneic 
spleen cells. Spleen cells used for stimulation were from C3H (H-2b, Mise), C57BL/6 
(H-2b, Mls~, DBA/2 (H-2d, Mlsa) and, as a control, BALB/c (H-2d, Mise). Fig. 1 shows 
the results from a comparison of the responses of three doses ofT cells from GF-CD 
and conventional BALB/c mice. The data indicate that GF-CD T cells can mount the 
same responses as conventional mice, with a comparable dose-response relationship, 
both after stimulation by cells of a different MHC haplotype, C57BL/6 and C3H, and 
to MHC-compatible cells presenting a different minor lymphocyte stimulating (Mis) 
antigen, DBA/2. These findings show that GF-CD T cells can be activated by 
recognition of allogeneic MHC molecules and associated antigens via the TcR. BALB jc 
GF-CD T cells, however, did not respond to cells from conventional BALB/c mice. 
In vitro stimulation test for lymphokine secretion by GF-CD spleen cells 
Studies on the B cell development in GF-CD mice have shown a highly reduced 
number of cells secreting lg of the non-lgM isotypes (16, 17) and have indicated that 
mitogenic stimulation could induce isotype switching in GF-CD splenic B cells (33). The 
presence of T cells with functional capabilities in combination with a highly reduced 
number of cells secreting lg of "switched" isotypes could indicate that either GF-CD T 
cells were not able to secrete lymphokines after stimulation, GF-CD B cells were not 
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Figure 1. Allogeneic responses of different doses of splenic T cells from GF-CD (solid columns) and 
conventional (open columns) BALB/c mice to irradiated spleen cells from various donors. 
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capable of responding to secreted lymphokines by isotype switching or that repertoire 
selection prevented T cells from lymphokine secretion induced by self-antigens. To test 
these hypotheses, high density cultures of 2 x 107 spleen cells in 2 ml medium were 
set up in 15 ml culture flasks coated with anti-CD3 antibody, to induce TcR complex 
crosslinking. Simultaneous cultures were set up with GF-CD and SPF BALB/c spleen 
cells in anti-CD3 and control coated culture flasks. Cells were harvested at days 0, 1, 
3, 4 and 5, counted and assayed for cells secreting IFN-r and lg of various isotypes. 
Figs. 2 and 3 show the results from these tests. Fig. 2a indicates a marked difference 
in the percentage of GF-CD cells surviving in anti-CD3 stimulated and unstimulated 
cultures. The results from SPF spleen cells were very similar. Fig. 2b shows the 
secretion of IFN-r by anti-CD3 stimulated GF-CD and SPF spleen cells and the 
development of IFN-r secreting spleen cells in cultures not stimulated with anti-CD3. 
number of surviving cells 
1.0x10• ~'o----------,.,-"'-,.,n--,1 ~r-\-----------s-P'F I 
0.5x10• ~ ~0 
~ B 
::J 
"" 
0 2 3 4 5 0 2 3 4 5 
days in culture ::Ju 
.... 
number of interferon-y secreting cells Q) a. 
,.--------------------------, r------------------------~ .!!1 ~ 103 
102 
GF-CD 
~
SPF 
~
101 
c 0 D 
0 2 3 4 5 0 2 3 4 5 
days in culture 
Figure 2. In vitro stimulation of spleen cells from GF-CD and SPF BALBjc mice by anti-CD3 
crosslinking. e : stimulated cultures, o : control cultures. Responses represent numbers of surviving 
cells and numbers of IFN-r secreting cells. 
Fig. 3 shows the development of lgSC of various isotypes after in vitro stimulation. The 
data indicate that in vitro stimulation of GF-CD spleen cells can induce the develop-
ment of cells secreting lg of non-lgM isotypes. The presence of cells secreting lgG1, 
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lgG2a and lgA indicate the secretion of IL-4, IFN-r and IL-5, respectively (34). These 
findings show that GF-CD T cells can be induced to secrete various lymphokines and 
that GF-CD B cells are able to respond to these factors by isotype switching. On basis 
of these results the marginal frequency of cells secreting lg other than lgM is most 
likely the consequence of negative selection (3,35,36) of the T cell repertoire for cells 
displaying autoreactivity resulting in lymphokine secretion. 
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Figure 3. In vitro stimulation of spleen cells from e: GF-CD and 0 : SPF BALB/c mice by anti-CD3 
crosslinking. Responses represent numbers of lgSC of various isotypes. 
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FACS analysis of ll-2R expression on GF-CD spleen and lymph node cells 
Besides negative selection, positive selection (37,39) is considered an 
important process in the maturation of thymocytes. The presence of functional T cells 
in GF-CD mice supports evidence from radiation chimaera experiments (40), that 
suggested the role of self-peptides in the positive selection of the T cell repertoire. 
Thus it could be speculated that GF-CD T cells recognize self-antigens in the peripheral 
lymphoid organs, but that their response to these stimuli is of a limited nature. A way 
to test this hypothesis is to analyze the activational state ofT cells in GF-CD mice. For 
this purpose spleen and lymph node cells from GF-CD mice were analyzed for 
expression of the IL-2R, a marker for activated T cells (41 ,42). Table 1 summarizes the 
data of the FACS analysis. The data indicate the presence of a significant population 
of IL-2R positive T cells in the spleens of GF-CD and conventional mice, but its minor 
presence in the lymph nodes. 
TABLE 1. Flow cytometry analysis of IL-2R expression on spleen and lymph node cells !rom GF-
CD and conventional BALBjc mice 
Organ et/31 et/31L-2R IL-2Rja{32 CD4 CD41L-2R IL-2R/CD43 
Spleen cells 
GF-CD 
Conventional 
Lymph node cells 
GF-CD 
Conventional 
66.3 
61.4 
69.8 
71.3 
8.4 
3.7 
0.8 
0.6 
1. Percentage of cells positive for TcR-a.B. 
11.2 
5.6 
1.1 
0.8 
46.8 
47.9 
49.3 
52.1 
4.8 
2.6 
0.5 
0.4 
2. Percentage of cells in population of TcR-a.B positive cells carrying the IL-2R. 
3. Percentage of cells in population of CD4 positive cells carrying the IL-2R. 
limiting dilution analysis of high affinity ll-2R expression 
9.4 
5.2 
1.0 
0.8 
The antibody to the IL-2R used for FACS analysis cannot distinguish the low 
54 
Autonomous T cell activation in GF-CD mice 
affinity from the functional high affinity IL-2R. In order to draw a more definite 
conclusion on the presence of activated T cells in the spleens of GF-CD mice, a limiting 
dilution analysis of purified T cells on IL-2 was performed. The data shown in Fig. 4 
yield comparable frequencies of IL-2 responsive cells in both GF-CD and conventional 
spleens. These findings indicate the presence of activated T cells in mice that have not 
encountered exogenous antigenic stimulation. 
cells per culture 
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Figure 4. Limiting dilution analysis of functional IL-2R expression on spleen cells from A: GF-CD and 
8: conventional BALB/c mice. 
DISCUSSION 
The results of this investigation establish the presence of activated T cells in 
germfree mice fed a chemically defined ultrafiltered low molecular diet, which are 
considered to be antigen-free. One explanation for this background activity within the 
immune system could be, that it should be prepared at all times to defend the host 
against the exogenous threat of a variety of infectious agents. This concept is 
challenging, because it presumes that the immune system, which is an excellent 
learning-machine, even without any previous encounters with exogenous antigen, 
would know of such threats. It can of course be argued that evolutionary shaping of 
the immune system in hosts that have received multitudes of exogenous stimuli, has 
caused a genetic predisposition for this background activity. Ontogenetic and 
physiological studies, however, have shown that a variety of other cells, e.g. nerve 
cells, muscle cells and cells secreting various hormones, do not develop their 
specialized functions when they do not receive appropriate stimuli, and that they 
gradually lose these functions when these stimuli are stopped. The immune system 
could of course be an exception to this rule, but we favor another explanation for its 
background activity. The observed autonomous function in GF-CD mice could also 
reflect, that host-defense is only one of the functions of the immune system (12, 13). 
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The presence of activated T cells in mice displaying only marginal levels of 
lg of switched isotypes indicates the important role of the selectional processes within 
the thymus. Our results could suggest that thymically educated T cells display a low 
extent of autoreactivity that allows them to react to self-antigens, but not to secrete 
certain lymphokines after these encounters. From this point of view thymic education 
could be considered as a process of fine-tuning. This fine-tuning may be exemplified 
by the demonstration that T cell hybridomas only need 300 complexes of MHC 
molecules and specific antigenic peptides at the surface of antigen presenting cells to 
be stimulated {43). Combining the concept of thymic fine-tuning, the assumption that 
T cells have no a priori knowledge of the origin of the peptides that they recognize, 
and the demonstration of the ability of COS-positive T cells to specifically lyse target-
cells, it could be speculated that the immune system is a self-referential system very 
capable of providing host defense. From this point of view thymic education would 
learnT cells to respond to cells displaying sets of peptides quantitatively or qualitatively 
different from the ones encountered during positive selection in the thymus. These 
responses could result in the production of factors like IL-2, which can activate 
cytotoxic T cells, or factors like IL-4, which can activate B cells. According to this 
concept, which in this respect is similar to a hypothesis on alloreactivity (44), any 
cause of an altered set of peptides presented on MHC molecules, be it infection, 
transformation or any other cause of cellular dysfunction, could activate educated T 
cells to induce appropriate responses. The concept of the immune system as a self-
referential system is speculative, but can be of great importance for our understanding 
of the various mechanisms that may cause autoimmune diseases. 
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IN VIVO TREATMENT WITH MONOCLONAL ANTI-I-A ANTIBODIES 
CAUSES A RAPID DISAPPEARANCE OF SPLENIC T CELLS AND 
BACKGROUND IMMUNOGLOBULIN SECRETING CELLS 
Quirijn Vos 1 and Ada M. Kruisbeek2 
1Department of Immunology, Erasmus University, Rotterdam, The Netherlands and2Biological Response 
Modifiers Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 
SUMMARY 
We have studied the effect of in vivo treatment with anti-1-A antibody on the 
background immunoglobulin secreting cells (lgSC) in the murine spleen. For this 
purpose groups of C57BL/6 mice received two intraperitoneal injections of monoclonal 
anti-1-A b or control anti-1-A k antibody of the lgG2a isotype. The treatment with anti-1-
A b antibody resulted in a rapid decrease of the total number of spleen cells, the 
number of splenic T cells and the frequency of background lgSC, which was most 
predominant for the non-lgM isotypes. These data suggest that interactions between 
MHC class II restricted T cells and antigen-presenting cells carrying these molecules 
are involved in the development of background lgSC, and in peripheral T cell renewal. 
The rapid disappearance and reappearance of both cell types after anti-1-A treatment 
indicate a high turnover of these cells in the murine spleen. 
INTRODUCTION 
CD4-positive T cells require concomitant recognition of antigen and MHC class 
II molecules to respond to antigenic stimulation by lymphokine production and 
proliferation [1-4]. Antibodies against MHC class II molecules have been used to study 
the functional role of surface 1-A molecules in in vitro assays [5-12]. These studies 
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have demonstrated that the inhibition of T cell function by anti-1-A antibodies in vitro 
is not due to a direct effect of the antibodies on the T cell, but to an interference in 
the recognition of 1-A determinants [5-7]. 
Studies using in vivo administration of anti-1-A antibodies have shown the 
inhibitory effect of this treatment on the immune responses against a variety of 
antigens [13, 17]. Moreover, in vivo treatment with anti-I-A antibodies has been shown 
to prevent graft-rejection [13] and graft-vs-host disease [14], as well as to suppress 
experimental myasthenia gravis [18], experimental encephalitis [19] and autoantibody 
production in (NZB x NZW)F1 mice [20]. Investigations of the mechanisms responsible 
for the loss of antigen presenting function of spleen cells treated in vivo with anti-1-A 
antibodies have shown a down-regulation of surface 1-A and 1-E expression, which 
was dependent of the dose of antibody administered [21 ,22]. 
Unmanipulated mice display background activity within the immune system 
which has been demonstrated forB [23] as well as T cells [24]. A comparison of the 
background lgSC from conventional mice and mice living in complete absence of 
exogenous antigenic stimulation [25,26] has indicated the role of exogenous antigens 
in the activation ofT cells to secrete lymphokines inducing isotype-switching [27] in the 
B cells of conventional mice. 
In order to study the importance of T cell - 1-A interactions in the development 
of splenic background lgSC, we have treated mice in vivo with anti-1-A antibody. This 
treatment resulted in a rapid decrease of background lgSC, which was most 
predominant for cells secreting the non-lgM isotypes, and in a rapid recovery 
thereafter. This finding indicated the role of T cell - MHC class II interactions in the 
development of background lgSC. The anti-1-A treatment also caused a decrease in 
the total number of spleen cells and the number of splenic T cells, indicating the 
importance of MHC class II restricted interactions in peripheral T cell renewal, as well. 
MATERIALS AND METHODS 
Mice 
C57BL/6 mice, 8 to 12 weeks of age, were obtained from the National Cancer 
Institute (Frederick, MD). 
In vivo anti-1-A treatment 
Anti-l-Ab, Y3P [28], and control anti-1-Ak, 10.3.6 [29], were purified from nude 
mice ascites by ammonium sulphate precipitation and Sephadex column size 
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separation. Concentrated antibodies were dialyzed against PBS, filter sterilized, and the 
concentration of the antibodies was determined by spectrophotometric absorbance. 
Mice were randomly divided in two groups, one receiving anti-l-Ab, the other the 
control anti-1-Ak. Mice received two intraperitoneal injections of antibody: 0.5 mg at day 
0, and 0.2 mg at day 1. 
Enumeration of splenic T cells 
Splenic T cells were isolated by treatment of splenocytes with anti-I-A b (Y3P) 
and complement followed by density gradient separation (Lympholyte-M; Cedar Lane, 
Ontario, Canada). Cells were counted using a hemocytometer. 
Enumeration of background lgSC 
lgSC of various isotypes were detected by the spot ELISA [30] with some 
modifications described previously [31]. 
RESUlTS AND DISCUSSION 
Effect of in vivo.anti-1-A treatment on the total number of spleen cells 
In order to study the effect of in vivo treatment with anti-1-A antibody, groups 
of C57BL/6 mice, chosen for their lack of 1-E expression, were treated with two 
injections, 0.5 mg on day 0 and 0.2 mg on day 1, of purified anti-I-A b or control anti-
1-Ak antibody, both of murine origin and lgG2a isotype. The dosage scheme was 
chosen since previous work [22] indicated that this treatment would result in a 
reappearance of 1-A surface expression at day 2 after the first injection. On the first day 
of treatment already a significant reduction of the total number of spleen cells was 
found (Fig. 1). The data show a maximal decrease of 60% at ·day 2 for anti-l-Ab 
treatment, whereas no reduction was observed after control treatment. The data also 
indicate a rapid recovery at day 3, one day after the previously indicated moment of 
1-A reexpression. Both anti-l-Ab and, more predominantly, control treatment caused an 
increase in the total numbers of spleen cells at day 4, which was also demonstrated 
for the number of splenic T cells and background lgSC. It could be speculated that in 
vivo administration of a high dose of antibodies, likely to contain some mitogenic 
impurities next to their idiotypic determinants, can induce such a response. Previously 
it has been shown that immunisation of mice with sheep red blood cells could induce 
a significant increase of background lgSC at day 4 after injection [32]. Comparison of 
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time and order of magnitude could indicate that the increase observed in the present 
experiments was caused by an aspecific response to the injected antibodies. 
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Figure 1. Effect of in vivo treatment with anti-1-
A antibodies on the total numbers of spleen 
cells. e :anti-l-Ab treatment; o : control anti-1-
Ak treatment. Results are shown as ~he geo-
metric mean ± S.E.M. of 5 individually tested 
mice. 
Effect of in vivo anti-1-A treatment on the number of 1-A negative spleen cells 
The data in Fig. 1 show a 60% reduction of spleen cells at day 2 after the first 
anti-I-A b treatment. Assuming that about 50% of all spleen cells are B cells and that the 
administered dose of antibody could not have removed all 1-A b positive cells, it could 
be concluded that B cells were not the only population which was reduced by the 
treatment. FACS analysis was performed to test this hypothesis, but in vivo treatment 
with anti-1-A antibody increased the aspecific backgrounds of both groups to such 
extent, that no reliable analysis could be done. In order to have an indirect way to 
quantitate a group of cells different from background lgSC, spleen cells of each group 
were pooled and treated with anti-I-A b and complement to determine the pool size of 
splenic !-A-negative cells, presumably largely T cells. Fig. 2 shows the effects of both 
treatments on this T cell enriched fraction and indicates a rapid decrease of splenic T 
cells after anti-I-A b treatment. Since the anti-I-A k antibody did not induce a comparable 
reduction, the effects of anti-1-A b treatment cannot be explained by a removal of cells 
binding the administered antibodies via Fc-receptors. The aspecific response at day 
4 was already discussed above. Based on reports on the daily thymic T cell output 
[33], the rapid disappearance and reappearance cannot be explained by demonstrated 
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effects [34] of anti-f-A treatment on the thymus. Our data therefore indicate the 
importance of MHC class II interactions for the maintenance of the peripheral T cell 
pool and support reports on the high turnover rate of peripheral T cells [35,36]. 
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Figure 2. Effect of in vivo treatment with anti-1-
A antibodies on the number of splenic 1-A nega-
tive (f) cells. • : anti-l-Ab treatment; D : control 
anti-1-Ak treatment. Results are the numbers 
resulting from a pool of 1-A negative spleen cells 
from 5 mice. 
Effect of in vivo anti-1-A treatment on splenic background lgSC of various 
isotypes 
Since treatment with control anti-f-A k antibody caused an aspecific response, 
we have used the following protocol for data analysis. Each day the data of 5 individual 
mice per treatment were collected and their geometric mean was calculated. In order 
to compensate for aspecific effects the mean of the anti-f-A b group was divided by the 
mean of the control group. Fig. 3 shows the resulting percentages ± S.E.M. for the 
isotypes assayed. The data indicate a rapid reduction of lgSC of all isotypes, with the 
smallest decrease and fastest recovery for lgM secreting cells and a reduction of 60% 
for lgG1-SC at day 3. These data support a report on the short half-life and high 
renewal rate of background lgSC in the spleen [37]. 
The observed reduction of lgSC can be explained by three mechanisms: (a) 
cytotoxicity of the administered antibody; (b) interference with T cell independent B cell 
maturation; and (c) activation and blocking ofT cell influence on these processes. The 
difference in kinetics of lgM- and lgG1-SC indicate that direct cytotoxicity cannot solely 
be responsible for the effects of anti-l-Ab treatment. Direct effects of anti-MHC class II 
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Figure 3. Effect of in vivo treatment with anti-1-A antibodies on the numbers of lgSC of various isotypes 
in the spleen. Results are shown as the percentage of cells compared with a negative control group. 
Results are shown as the geometric mean± S.E.M. of 5 individually tested mice. 
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antibodies on the activation of human B cells have been shown [38,39] and can be 
a cause of the observed effects, especially the reduction of the pool of immature B 
cells indicated by Figs. 1 and 2. It can, however, not account for the differences 
between the various isotypes. With regard of the observed reduction of splenic B cells, 
the data shown in Fig. 3 can most likely be explained by interference with T cell 
dependent B cell differentiation and activation. Bearing in mind that the frequency of 
splenic lgM-SC is approximately 25 times higher than of lgG-SC of various isotypes, 
we propose the following hypothesis on the mechanism causing the effects of in vivo 
anti-1-A treatment shown in this communication. 
Injection of anti-1-A antibody causes a limited reduction of all 1-A positive cells 
by direct cytotoxicity, which will be most predominant directly after injection, and by a 
direct effect on B cell maturation involving a blocking and down-regulation of surface 
1-A expression. This down-regulation interferes with T cell induced B cell switching from 
lgM to the other isotypes causing an extra reduction of these. The blocking also 
interferes with the signals that T cells need for their peripheral renewal, causing their 
decrease and a further reduction of the numbers of cells secreting "switched" isotypes. 
As soon as anti-1-A levels drop, MHC class II molecules start to reappear and a return 
to the normal situation occurs. 
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CHAPTER 7 
GENERAL DISCUSSION 
7 .1.1 The results from Chapter 3 
The results shown in Chapter 3 demonstrate that the usage of a technique 
employing coated capture antibodies and enzyme-labeled insulin can greatly improve 
the sensitivity of the conventional spot-ELISA for the detection of cells secreting 
antibodies of the lgG isotypes. Moreover an improved protocol for the detection of 
immunoglobulin-secreting cells (lgSC) was described, which was used in some of the 
experiments described in Chapters 4 to 6. 
7 .1.2 The results from Chapter 4 
The results shown in Chapter 4 demonstrate that functional T cells can develop 
in mice that have not received exogenous antigenic stimulation. Moreover, analysis of 
the expression ofT cell receptor Vf3 chains on mature thymocytes and peripheral T 
cells from germfree mice fed a chemically defined diet (GF-CD) indicated no significant 
differences with the expression in conventional mice. These results have a number of 
important implications. 
Firstly they show the high degree of autonomy in T cell development. This 
autonomy indicates that self-antigens are a sufficient source of peptides for the 
development of thymocytes by both positive and negative selection and the 
maintenance of peripheral T cells. 
Secondly they indicate that the influence of exogenous antigens on these 
processes is of a limited nature only. 
Thirdly they challenge current concepts on autoreactivity of T cells as they 
support evidence on the role of self-peptides in the positive selection of thymocytes 
and indicate that self-recognition can result in the maturation to mature T cells. 
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7.1.3 The results from Chapter 5 
The results from the experiments described in Chapter 5 give a further 
illustration of the functional properties of GF-CD T cells and indicate the presence of 
activated cells within this population. 
The response of GF-CD T cells to allogeneic stimulator cells demonstrates their 
ability to be triggered by stimuli involving T cell receptor (TcR) mediated recognition 
of MHC molecules and associated peptides. Another not eye-catching but yet 
important result, which will be discussed further on, is the lack of response of GF-CD 
T cells to cells from syngeneic conventional mice. 
The results from the in vitro stimulation experiments indicate that GF-CD T cells 
are able to respond to TcR crosslinking by lymphokine secretion and that GF-CD B 
cells can be induced to isotype switching. These findings demonstrate that the severely 
reduced numbers of lgSC of the non-lgM isotypes detected in GF-CD mice are not 
caused by functional defects in their T and/or B cells. 
The results from the flow cytometry analysis of IL-2 receptor expression and 
from the limiting dilution analysis of GF-CD T cells on IL-2 indicate the presence of 
activated T cells in mice that have not received exogenous antigenic stimulation. 
Together with the earlier results from studies on the B cell compartment of GF-CD mice 
these findings demonstrate functional activity within the immune system of these mice. 
This activity is due to an internal activation within the immune system since the GF-
CD mice do not need, and actually do not mount, a host-defense against invasive 
pathogenic micro-organisms. 
7 .1.4 The results from Chapter 6 
The results shown in Chapter 6 demonstrate the importance of cell interactions 
involving the recognition of MHC molecules and associated peptides for the internal 
activation within the immune system. The rapid disappearance of lgSC of the non-lgM 
isotypes after in vivo treatment with anti-MHC class II antibodies indicates the 
importance of helper T cells and their isotype-switch inducing lymphokines on the 
development of these cells. The small decrease in cells secreting lgM indicate the 
limited influence of T cells on their differentiation. 
This stands in clear contrast to the dependence of lgSC producing other 
isotypes on T cell- MHC class II interaction. The decrease in the number of peripheral 
T cells after treatment illustrates the necessity of the interaction between helper T cells 
and antigen presenting cells for the maintenance of the T cell pool. Although the 
results from Chapter 6 allow no direct conclusion, it may be speculated on the basis 
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of reports on the peripheral renewal ofT cells, that the observed decrease is the result 
from a blockade of the stimuli inducing the peripheral clonal expansion ofT cells. The 
kinetics of the phenomena observed give further proof to previous observations on the 
short half life and the high renewal rate of the majority of cells within the pool of 
peripheral lymphocytes. 
7.2 Self, non-self and the immune system 
Studies on the properties of the receptors expressed by mature T cells have 
shown that 1 in every 10,000 T cells reacts with a certain peptide presented by a 
syngeneic cell (1). Such studies have also demonstrated that the presence of 300 
complexes of a specific peptide with MHC on the surface of an antigen-presenting cell 
(i.e. an 0.1% occupation of all MHC molecules) is sufficient to trigger T cells (2). These 
findings suggest that T cells resulting from thymic education carry receptors with a 
high degree of antigenic specificity, and display a high sensitivity in their specific 
recognition. 
Due to the absence of exogenous antigenic stimulation, in GF-CD mice both 
positive (3) and negative selection (4) of thymocytes can only be induced by the 
recognition of self-peptides presented in the context of self-MHC molecules. 
The identical patterns of clonal deletion observed in GF-CD and conventional 
mice support on the one hand current ideas on the importance of negative selection 
for the removal of thymocytes displaying self-reactivity, since the GF-CD mice have 
self-antigens as the only source of MHC associated peptides. 
The demonstration of mature thymocytes and of functional T cells in GF-CD 
mice, on the other hand, support a report indicating the importance of the recognition 
of MHC associated self-peptides in the positive selection of thymocytes (5). 
This seemingly contradictory role of self-recognition in two processes of 
opposed nature can be explained by the interpretation of negative and positive 
selection as two mechanisms setting the upper and lower limits in a process of fine-
tuning. This fine-tuning would result in a population of mature thymocytes that display 
a well-defined low extent of self-recognition. Taking into account the observations 
mentioned in the beginning of this section, such a low extent of self-reactivity could be 
based on the recognition of a particular self-peptide which is presented by MHC 
molecules on the surface of thymic antigen-presenting cells like epithelial cells, macro-
phages or dendritic cells in numbers lower than about 300 per cell. From this point of 
view the auto reactivity which T cells have been demonstrated to display under in vitro 
culture conditions (6-8) can be explained by the increased presentation of self-peptides 
that these conditions allow. The reactivity to non-self peptides could be explained by 
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cross-reactivity ofT cell receptors (9). 
Besides this new concept on T cells and autoreactivity the results presented 
in Chapters 5 and 6 could support some ideas on its consequences. 
The results of the allogeneic stimulation assays presented in Chapter 5 indicate 
that GF-CD T cells do not respond in vitro to cells from syngeneic conventional mice. 
Since the flow cytometry analysis of GF-CD T cells indicated the same repertoire of 
TcR Vft chains as conventional mice, this lack of response could mean that the 
repertoire of peptides presented by splenic antigen presenting cells from conventional 
mice is similar to that of corresponding cells from GF-CD mice, and consists mainly of 
self-peptides. 
Based on the findings of Chapter 6, which indicated that an interference in the 
recognition of MHC molecules resulted in a rapid decrease of the peripheral T cell 
pool, it could be speculated that the maintenance of the pool of peripheral T cells, 
which is highly dependent of cell division (10), is induced by the recognition of MHC-
associated self-peptides (11). This speculation would indicate a dramatic contrast 
between the way T cells respond to syngeneic stimuli under in vitro and in vivo 
conditions. 
This speculation and its theoretical backgrounds may seem highly improbable, 
but on the other hand the data from Chapters 5 and 6 support a report on the 
differences between T cell proliferation under in vitro and in vivo conditions (12). Based 
on these ideas thymic education would lead to a repertoire ofT cells whose low extent 
of self-reactivity allows them on the one hand to divide upon interaction with self-
peptides, but on the other hand not to initiate an autoimmune response. 
Any perturbation of the set of peptides presented by the peripheral antigen-
presenting cells could activate the immune system to humoral and or cellular 
responses which allow the establishment of a new state of homeostasis. These 
perturbations could be induced by exogenous antigens leading the immune system to 
function as a host defense system, or could be induced by increased amounts of self 
antigens or by "neo-self" antigens caused by biochemical malfunctions, mutations or 
transformations. 
From this point of view the immune system could be defined as the molecular 
equivalent of the nervous system with a task as a self-referential system (13), 
monitoring the molecular homeostasis of a large variety of specialized differentiated 
cells. In contrast to current ideas, self-recognition and self-assessment would be of 
great importance for this system and could be the stimuli responsible for the 
completeness and functional status of the immune system. 
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SUMMARY 
This thesis describes three areas of immunological research: 
- Firstly the development of an immunological technique which allows an improved 
detection of cells secreting specific antibodies. The results of this study demonstrated 
that the use of a protocol employing coated capture antibodies and enzyme-labeled 
antigen in stead of the sandwich-method employing antigen coating and enzyme-
labeled detector antibodies could considerably improve the detection of cells secreting 
antibodies of the lgG isotypes. 
- Secondly an investigation of the immune system of germfree mice, fed an ultrafiltered 
chemically defined low-molecular diet. Such mice are considered to be completely free 
of exogenous antigens. Previous studies have shown that such mice have similar 
numbers of B cells and background lgM secreting cells as conventional mice, but are 
highly deficient in background lgG and lgA production. The results of our study 
demonstrated that such mice had a normal repertoire of functional T cells, that could 
be induced to lymphokine secretion, and that the absence of background im-
munoglobulin secreting cells of the non-lgM isotypes was not caused by defects in 
their B or T cells. This data indicates that the immune system has an autonomous 
activity, which is independent of exogenous antigenic stimulation. 
- Thirdly a study on the effects of the manipulation of the immune system with 
antibodies against MHC class II molecules. The results of this study demonstrated that 
in vivo treatment with antibodies directed against the MHC class II molecules caused 
a rapid decrease in the number of background immunoglobulin secreting cells and T 
cells in the spleen. This indicates that the generation of background immunoglobulin 
secreting cells and the maintenance of the T cell compartment are dependent on 
cognate interactions within the immune system involving MHC class II. 
The combined results from these studies indicate that self-recognition is of 
great importance for the autonomous activity of the immune system. 
By defining the immune system as a host-defense system, it has been 
postulated that the cells involved in this system should react to foreign antigens, but 
ignore self-molecules. Based on the observation of self-recognition within the system 
we conclude that host-defense is one among the tasks of the immune system, which 
could be considered as the molecular equivalent of the nervous system. 
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SAMENVATIING 
Dit proefschrift beschrijft drie terreinen van immunologisch onderzoek: 
- Ten eerste de ontwikkeling van een immunologische techniek, die een verbeterde 
detectie van antilichaam-secernerende cellen mogelijk maakt. Deze techniek maakt 
gebruik van ge"immobiliseerde antilichamen en enzym-geconjugeerd antigeen in plaats 
van de toepassing van de sandwich-methode, die gebaseerd is op de immobilisatie 
van antigeen en detectie met enzym-geconjugeerde tweede staps antilichamen. De 
resultaten van dit onderzoek tonen aan dat deze nieuwe techniek de detectie van lgG 
antilichaam secernerende cellen aanzienlijk kan verbeteren. 
- Ten tweede een onderzoek van het immuunsysteem van niet-geTmmuniseerde 
kiemvrije muizen, die gevoed werden met een ultragefiltreerd dieet bestaande uit 
laagmoleculaire voedingsstoffen. Eerdere studies hebben aangetoond dat zulke muizen 
aantallen B-cellen en lgM secernerende cellen bezitten, die vergelijkbaar zijn met 
conventionele muizen, maar een grate deficientie in "achtergrond" lgG en lgA productie 
hebben. Deze muizen worden geheel vrij van exogene antigenen beschouwd. De 
resultaten van onze studie ton en aan, dat zulke muizen- een normaal repertoire van 
functionele T-cellen hebben die tot lymfokine secretie kunnen worden gestimuleerd, 
en dat de afwezigheid van "achtergrond" immunoglobuline secernerende cellen van 
andere dan lgM isotype niet veroorzaakt wordt door defecten in hun B- of T-cellen. Dit 
toont aan dat het immuunsysteem een autonome activiteit bezit, die onafhankelijk is 
van exogene antigene stimulatie. 
- Ten derde een onderzoek naar de gevolgen van manipulatie van het immuunsys-
teem met antilichamen tegen MHC klasse II moleculen. De resultaten van deze studie 
tonen aan dat in vivo behandeling met antilichamen gericht tegen MHC klasse II 
moleculen een snelle verlaging veroorzaakte van het aantal "achtergrond" immuno-
globuline secernerende cellen en het aantal T-cellen in de milt. Dit duidt erop dat de 
vorming van "achtergrond" immunoglobuline secernerende cellen en de instand-
houding van het T-cel compartiment afhankelijk zijn van "cognate" interacties binnen 
het immuunsysteem via MHC klasse II moleculen. 
De gezamenlijke resultaten van deze studies ton en aan dat zelf-herkenning van 
groat belang is voor de autonome activiteit binnen het immuunsysteem. 
Door het immuunsysteem als afweersysteem te definieren, is gepostuleerd dat 
deze celpopulatie moest reageren op lichaamsvreemde antigenen, maar lichaams-
eigen antigenen moest negeren. Uitgaande van de waargenomen zelf-herkenning 
binnen het systeem concluderen wij dat de afweer tegen lichaamsvreemde antigen en 
slechts een van de taken van het immuunsysteem is, dat zou kunnen worden gezien 
als een moleculair equivalent van het zenuwstelsel. 
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AMP 
AP 
ASC 
5-BCIP 
BSA 
CFA 
DMEM 
ELISA 
FCS 
FITC 
GA 
GAM 
GAM-AP 
GF-CD 
HBSS 
HI 
HI-AP 
IFN--y 
lg 
lgSC 
ll-2 
ll-2R 
LPS 
MAb 
2-ME 
MHC 
MLS 
PBS 
PBT 0.1 
PBT 1.0 
PLN 
PNP 
RAM 
SPF 
slg 
TcR 
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UST OF ABBREVIATIONS 
: 2-amino-2-methyl-1-propanol 
: alkaline phosphatase 
: antibody-secreting cell(s) 
: 5-bromo-4-chloro-3-indolyl phosphate 
: bovine serum albumin 
: complete Freund's adjuvant 
: Dulbecco's modified Eagle's medium 
: enzyme-linked immunosorbent assay 
: fetal calf serum 
: fluorescein isothiocyanate 
: glutaraldehyde 
: goat antiserum directed against mouse lg 
: conjugate of GAM and AP 
:germfree (mice), fed a chemically defined ultrafiltered low-molecular diet 
: Hank's balanced salt solution 
: human insulin 
: conjugate of HI and AP 
: gamma interferon 
: immunoglobulin(s) 
: immunoglobulin-secreting cell(s) 
: interleukin 2 
: interleukin 2 receptor 
: lipopolysaccharide 
: monoclonal antibody 
: .B-mercaptoethanol 
: major histocompatibility complex 
: minor lymphocyte stimulating antigen 
: phosphate-buffered saline 
:PBS containing 0.1% BSA and 0.1% Tween 20 
: PBS containing 1.0% BSA and 0.1% Tween 20 
: popliteal lymph nodes 
: p-nitrophenyl phosphate 
: rat MAb directed against mouse lg 
: specific pathogen free 
:surface immunoglobulin(s) 
: T cell receptor 
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